| |
| |
|
| Insider
Information: |
Wyzga Michael S |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
80,725 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$256,285 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
80,725 |
|
|
| Total
Value |
$256,285 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -6.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
Executive VP and CFO |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-03-25 |
1,500 |
2014-03-25 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2021-02-26 |
2,558 |
2015-07-23 |
0 |
Premium* |
|
|
Logicbio Therapeutics, Inc. |
LOGC |
Director |
2022-11-16 |
0 |
2021-01-01 |
0 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
Director |
2023-08-18 |
76,667 |
2022-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2023-08-18 |
4 |
B |
$1.20 |
$29,875 |
D/D |
25,000 |
76,667 |
2.39 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
51,667 |
0 |
- |
|
| LOGC |
Logicbio Therapeutics, In... |
Director |
– • – |
2022-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,141) |
0 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
6,667 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-02-26 |
4 |
OE |
$26.98 |
$272,714 |
D/D |
10,108 |
21,579 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-02-26 |
4 |
AS |
$130.11 |
$2,474,822 |
D/D |
(19,021) |
2,558 |
0 |
% |
|
| LOGC |
Logicbio Therapeutics, In... |
Director |
– • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,141 |
3,141 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,558 |
11,471 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2019-07-31 |
4 |
AS |
$117.93 |
$589,650 |
D/D |
(5,000) |
8,913 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2019-07-31 |
4 |
OE |
$26.98 |
$67,450 |
D/D |
2,500 |
13,913 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2019-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,801 |
11,413 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2019-02-28 |
4 |
AS |
$96.00 |
$48,000 |
D/D |
(500) |
8,612 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2018-08-28 |
4 |
AS |
$74.85 |
$184,730 |
D/D |
(2,468) |
9,112 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
606 |
11,580 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2018-05-10 |
4 |
AS |
$51.53 |
$381,447 |
D/D |
(7,402) |
10,974 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2017-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
791 |
18,376 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2016-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,547 |
17,585 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2015-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,038 |
6,038 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-03-25 |
4 |
B |
$17.00 |
$25,500 |
D/D |
1,500 |
1,500 |
2.39 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$268,620 |
I/I |
(3,630) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,811,150 |
D/D |
(24,475) |
29,250 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,250 |
53,725 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2010-05-25 |
4 |
S |
$45.63 |
$231,253 |
D/D |
(5,068) |
24,024 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP and CFO |
• – – |
2010-05-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
29,092 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
